We recently compiled a list of the 10 Firms Post Impressive Gains on Monday. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks. Wall Street ended the first trading day of the week on a mixed note,

Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of tougher times ahead.

We recently published a list of Jim Cramer is Talking About These 10 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer is talking about.

Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in demand for the company’s blockbuster psoriasis treatment.

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee

Project Stargate will see companies like Oracle, SoftBank, MGX, and OpenAI commit an initial $100 billion to build data centers in the U.S.

What Hartford Funds and Ned Davis Research found was that income stocks more than doubled the average annual return of non-payers -- 9.17% versus 4.27% -- and did so while being less volatile than the benchmark S&P 500. However, high-quality dividend stocks don't grow on trees and require some effort by investors to uncover.

JNJ stock reporting earnings, expecting $2 EPS and $22.44B revenue, approval for Spravato, mixed chart signals, $167.71 price target - 13% upside

House Speaker Mike Johnson revealed President Biden insisted to him he hadn’t issued an executive order freezing liquid natural gas export permits — despite doing so less than a month

Johnson’s story was first reported by the Wall Street Journal in June, though the newspaper’s reporting relied on anonymous sources at the time. When Weiss asked Johnson to elaborate on his observations, the speaker began his tale of how Biden’s ...

Wall Street has perceived the company to have an almost unbreachable defense against competition with its offerings of high-tech chips. The company’s rapid growth and windfall profit have helped push other technology firms and the Nasdaq Composite Index to record after record,

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.sbqKNnJW.js